Clinical significance of measurement of interleukin 4 and interleukin 5 serum concentrations in bronchial asthma

Jugoslovenska Medicinska Biohemija

Volumn 23, Issue 1, 2004, Pages 51-54

  Bogić, Midana ^a   Savić, Nevena ^a   Jovičić, Žikica ^a   Spirić, Vesna Tomić ^a   Popadić, Aleksandra Perić ^a   Rašković, Sanvila ^a   Arandjelović, Snežana ^a   Šojić, Jasminka ^a   Čolić, Miodrag ^b  

^a CCS   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Asthma; Asthma severity; Interleukin 4; Interleukin 5

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 5;

ARTICLE; ASTHMA; ATOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE;

EID: 1842459616     PISSN: 03543447     EISSN: None     Source Type: Journal    
DOI: 10.2298/JMH0401051B     Document Type: Article

References (14)

1. Huang H, Hu-Lu J, Chen H, Ben-Sasson SZ, Paul WE. IL-4 and IL-13 Production in Differentiated T Helper Type 2 Cells Is Not IL-4 Dependent. The J Immunol 1997; 159: 3731-38.
2. Ohmori Y, Hamilton AT. IL-4 Induced STAT6 Suppresses IFN-γ -Stimulated STAT1-Dependent Transcription in Mouse Macrophages. J Immunol 1997; 159: 5474-82.
3. Dickensheets HL, Donnely PR. IFN-γ and IL-10 Inhibit Induction of IL-1 Receptor Type I and Type II Gene Expression by IL-4 and IL-13 in Human Moncytes. J Immunol 1997; 159: 6226-33.
4. Ergan RW, Umland SP, Cuss FM, Chapman RW. Biology of interelukin-5 and its relevance to allergic disease. Allergy 1996; 51:71-81.
5. Lai C KW, Ho ASS, Chan CHS, Tang J, Leung JCK, Lai KN. Interelukin-5 messenger RNA expression in peripheral blood CD4+ cells in asthma. J Allergy Clin Immunol 1996 (97): 1320-6.
6. National Heart Lung and Blood Institute National Institutes of Health. Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop Report NIH Pub No 95-3659,1995, Revised 2002, 2.
7. Motojima S, Akutsu I, Fukuda T, Makino S, Takatsu K. Clinical signifance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma. Allergy 1993; 48: 98-106.
8. Jekel JF, Elmore JG, Katy DL. Epidemiology Biostatistics and Preventive Medicine. Philadelphia, WB Saunders Company, 1996.
9. Erić-Marinković J, Dotlić R, Janošević S, Kocev N, Gajić M, Ille T, Stanisavljević D, Babić D. Statistika za istraživače u oblasti medicinskih nauka. Beograd, Medicinski fakultet, 2001.
10. Alexander AG, Barkans J, Moqbel R, Barnes NC, Kay B, Corrigan CJ. Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependant chronic severe asthma. Thorax 1994; 49: 1231-3.
11. Oymar K, Elsayed S, Bjerknes R. Serum eosinophil catoinic protein and interelukin-5 in children with bronchial asthma and acute bronchiolitis. Pediatr Allergy Immunol 1996; 7 (4): 180-6.
12. Matsumoto K, Taki F, Miura M, Matsuzaki M, Takagi K. Serum levels of soluble IL-2R, IL-4 and soluble Fc epsilon RII in adult bronchial asthma. Chest 1994; 105 (3): 681-6.
13. Hashimoto S, Amemiya E, Tomita Y, Arai K, Yamaguchi M, Horie T. Elevation of soluble IL-2 receptor and IL-4 and nonelevation of IFN-gamma in sera from patients with allergic asthma. Ann Allergy 1993; 71 (5): 455-8.
14. Hacken NH, Oosterohoff Y, Kauffman HF, Guevarra I, Satoh T, Tollerud DJ, et al. Elevated serum interferon-gamma in atopic asthma correlates with increased airways responsiveness and peak expiratory flow variation. Eur Resp J 1998; 11 (2): 312-6.